Cervical Pregnancy in a Primigravida Patient without Risk Factors: A Case Report

作     者：Dieudonné Sengeyi Mushengezi Amani Eloge Ilunga-Mbaya Francis Ebola Iyawa Berry Kinkenda Nsiangangu Dieudonné Sengeyi Mushengezi Amani;Eloge Ilunga-Mbaya;Francis Ebola Iyawa;Berry Kinkenda Nsiangangu

作者机构：Obstetrics Service Department of Gynecology and Obstetrics University Clinics of Kinshasa Lemba/Kinshasa XI/DRC Unikin Congo Gynecology Service Department of Gynecology and Obstetrics University Clinics of Kinshasa Kinshasa XI Unikin Congo 

出 版 物：《Open Journal of Obstetrics and Gynecology》 (妇产科期刊（英文）)

年 卷 期：2020年第10卷第6期

页      面：770-777页

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Cervical Pregnancy Risk Factors Hemorrhage Methotrexate 

摘      要：Cervical pregnancy is defined as the implantation of the egg below of the internal cervical orifice, and remains a rare clinical entity which affects on average 1 out of 20,000 pregnancies worldwide.Its hemorrhagic complications are life-threatening in case of late diagnosis. It occurs mainly on a history of curettage or caesarian which are the most recognized risk factors.The objective pursued here is to discuss the possibility of the occurrence of this rare clinical entity in a primigravida without risk factors and the different therapeutic possibilities according to the technical platforms.Authors report a case of cervical pregnancy at 6 weeks’gestation occurring in a primigravida without risk factors who consulted at University clinics of Kinshasa (UCK) for a genital hemorrhage chart. The diagnosis was made using ultrasound and treatment provided by curettage followed by the placement of an intra-cervical foley tube for hemostatic purposes.Given its high mortality, the diagnosis must be early even in pregnant women without obvious risk factors. The diversity of therapeutic means gives practitioners a choice depending on the technical platform.